Comvita hits new 5-year high on early results from diabetes prevention trial

Thu, 06 Sep 2012

By Pattrick Smellie Sept 6 (BusinessDesk) - Shares of Comvita rose 2.7 percent to a five-year high of $3.80 after a company statement detailed the results of medical research, yet to be peer-reviewed, showing its olive leaf extract boosts the effectiveness of insulin in overweight, middle-aged men at risk of diabetes. Undertaken by the Liggins Institute, a medical research centre of at the University of Auckland, the research examined "a range of complex health outcomes, including insulin responses among those trial participants who took fres...

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Markets market close
NZ shares fall as market rally evaporates
Dan Brunskill | Wed, 29 Jun 2022

A survey showed US consumer confidence was at its lowest since 2013.

Bloomberg
Donald Trump Steers Himself into a Legal Morass
Bloomberg | Wed, 29 Jun 2022

I don’t think anyone can doubt that Trump committed crimes, based on the testimony we’ve heard. Serious crimes. 

Infrastructure
Kiwi chair Mark Ford says property values may fall 5-10%
Jenny Ruth | Wed, 29 Jun 2022

Many of the factors weighing on Kiwi Property's share price are beyond its control, chair Mark Ford told shareholders.

Sponsored
Investments to sustain the momentum of building in NZ

Classic Capital has opened its Land & Build fund to qualified wholesale and eligible investors.

Sponsored
High water marks: Watercare raises the tide on sustainability

The No.1 barrier to decarbonisation for NZ organisations is accurate measurement, says Microsoft’s Accelerating the Journey to Net Zero report.